Try, Try Again: Bain And Cinven File Fresh Bid For Stada
Executive Summary
Stada is likely to approve a second takeover bid from equity groups Bain and Cinven soon, at a new price of €66.25 per share; an offer cleared by Germany's stock market authorities despite a ban in the country on repeat acquisition bids within 12 months.
You may also be interested in...
Stada Saga Set To End As Board Backs Bain And Cinven Bid
The equity firms finally look like getting their hands on the German generics group as Stada urges shareholders to back the €4.1bn deal and only 63% need to support it.
Stada Saga Set To End As Board Backs Bain And Cinven Bid
The equity firms finally look like getting their hands on the German generics group as Stada urges shareholders to back the €4.1bn deal and only 63% need to support it.
Commercial Capsules: Soriot, IPOs, Deals And Hemophilia Data
IPOs are up, hemophilia is driving company pipelines, speculation over Pascal Soriot's career plans drive billions from AstraZeneca's market capitalization, Sanofi signs a $650m vaccine deal, private equity bidders up their offer for Stada and earnings season kicks off. Commercial capsule rounds up recent business news and trends reported by sister publication Scrip.